A Brief Psychological Intervention for Carer Fear of Cancer Progression (NCT07752992) | Clinical Trial Compass
RecruitingNot Applicable
A Brief Psychological Intervention for Carer Fear of Cancer Progression
Denmark14 participantsStarted 2026-06-15
Plain-language summary
This study aims to evaluate the feasibility and acceptability of the Conquer Fear Carer Brief, a three-session psychological intervention targeting fear of cancer progression among caregivers of patients with metastatic prostate cancer.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Self-identified caregiver of a patient with metastatic, non-curable prostate cancer
* Aged ≥18 years
* Score in the clinical range (≥22) on the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF)
* Score in the clinical range (\>15) on the Brief Penn State Worry Questionnaire (PSWQ)
* Sufficient proficiency in Danish
* Able to provide informed consent
* Stable or no use of antidepressant or anxiolytic medication (i.e., stable dosage for ≥6 weeks)
* Able to participate in online-delivered therapy via a computer with a video camera
Exclusion Criteria:
* Severe psychiatric conditions (e.g., major depression) that would make participation in the intervention inappropriate
* Currently enrolled in psychotherapy or counseling targeting the same problem
* Substance abuse or dependence judged to require treatment
* Suicide risk requiring immediate psychiatric intervention or hospitalization
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Intervention feasibility: Treatment dropout rate
Timeframe: Post-treatment approximately 7 weeks after baseline (Time 2)
2
Intervention feasibility: Consent rate
Timeframe: Baseline (Time 0)
3
Intervention feasibility: Successfull recruitment
Timeframe: Baseline (Time 0)
4
Intervention feasibility: Change in fear of cancer progression from pre-intervention (Time 1) to post-intervention (Time 2) and follow-up (Time 3)
Timeframe: Follow-up approximately 22 weeks after baseline (Time 3)